<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35239007</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Genotype-phenotype association of TARDBP mutations in Chinese patients with amyotrophic lateral sclerosis: a single-center study and systematic review of published literature.</ArticleTitle><Pagination><StartPage>4204</StartPage><EndPage>4212</EndPage><MedlinePgn>4204-4212</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-11042-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study aims to determine the genetic and clinical features of TARDBP-mutated patients in our cohort of Chinese patients with amyotrophic lateral sclerosis (ALS) combined with data in the literature.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed TARDBP mutation screening in 1258 Chinese ALS patients, including 1204 sporadic ALS (sALS) and 54 familial ALS (fALS) patients. A systematic literature review was conducted by searching TARDBP-mutated patients from China in the online databases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In our cohort, the mutant frequency of TARDBP variants was 0.3% (4/1258), with two recurrent variants (p.G294V, p.G298V) and one novel variant (p.S332G) identified. Combining with data in the literature review, the TARDBP-mutant frequency in the Chinese population was 1.4% (83/5998), with 0.8% (46/5470) in sALS and 7.0% (37/528) in fALS. Most patients had limb onset (63.0%), with an average life expectancy of 4.3&#xa0;years (range 0.5-13). Disease durations significantly differed (p&#x2009;=&#x2009;0.002), with p.M337V showing the longest duration (80&#xa0;months) and p.N378D showing the shortest duration (16.7&#xa0;months).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study found that TARDBP mutation was not rare in Chinese fALS patients. Different TARDBP mutations were associated with specific features in phenotypes.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinyue</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College (CAMS, PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College (CAMS, PUMC), Beijing, China. drliuqing@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, CAMS, Beijing, China. drliuqing@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiaohan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College (CAMS, PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College (CAMS, PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shuangwu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College (CAMS, PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhili</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College (CAMS, PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xunzhe</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College (CAMS, PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingsheng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College (CAMS, PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Liying</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5369-1541</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College (CAMS, PUMC), Beijing, China. pumchcuily@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, CAMS, Beijing, China. pumchcuily@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>McKusick-Zhang Center for Genetic Medicine, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, CAMS, PUMC, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, CAMS, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>XDB39040100</GrantID><Agency>the Strategic Priority Research Program of the Chinese Academy of Sciences</Agency><Country/></Grant><Grant><GrantID>2021-1-I2M-034</GrantID><Agency>the CAMS Innovation Fund for Medical Sciences (CIFMS) grant</Agency><Country/></Grant><Grant><GrantID>2016-I2M-1-002</GrantID><Agency>the CAMS Innovation Fund for Medical Sciences (CIFMS) grant</Agency><Country/></Grant><Grant><GrantID>2021-1-I2M-018</GrantID><Agency>the CAMS Innovation Fund for Medical Sciences (CIFMS) grant</Agency><Country/></Grant><Grant><GrantID>81971293</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>81788101</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2016YFC0905100</GrantID><Agency>the National Key Research and Development Program of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="Y">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Chinese</Keyword><Keyword MajorTopicYN="N">Genotype</Keyword><Keyword MajorTopicYN="N">Phenotype</Keyword><Keyword MajorTopicYN="N">TARDBP</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>12</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35239007</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-11042-w</ArticleId><ArticleId IdType="pii">10.1007/s00415-022-11042-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP (2017) Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 88:540&#x2013;549. https://doi.org/10.1136/jnnp-2016-315018</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadi G, Maximino JR, Jorge FMH, Borba FC, Gilio JM, Callegaro D, Lopes CG, Santos SND, Rebelo GNS (2017) Genetic analysis of patients with familial and sporadic amyotrophic lateral sclerosis in a Brazilian Research Center. Amyotroph Lateral Scler Frontotemporal Degener 18:249&#x2013;255. https://doi.org/10.1080/21678421.2016.1254245</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1254245</ArticleId><ArticleId IdType="pubmed">27978769</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Schulte DJ, Ravits J (2015) Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin 33:855&#x2013;876. https://doi.org/10.1016/j.ncl.2015.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId><ArticleId IdType="pmc">4628785</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ (2013) Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 125:777&#x2013;794. https://doi.org/10.1007/s00401-013-1125-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId><ArticleId IdType="pmc">3661910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye CH, Lu XL, Zheng MY, Zhen J, Li ZP, Shi L, Liu ZY, Feng LY, Pei Z, Yao XL (2013) Absence of mutations in exon 6 of the TARDBP gene in 207 Chinese patients with sporadic amyotrohic lateral sclerosis. PLoS ONE 8:e68106. https://doi.org/10.1371/journal.pone.0068106</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0068106</ArticleId><ArticleId IdType="pubmed">23874513</ArticleId><ArticleId IdType="pmc">3706600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou L, Jiao B, Xiao T, Zhou L, Zhou Z, Du J, Yan X, Wang J, Tang B, Shen L (2016) Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China. Sci Rep 6:32478. https://doi.org/10.1038/srep32478</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep32478</ArticleId><ArticleId IdType="pubmed">27604643</ArticleId><ArticleId IdType="pmc">5015023</ArticleId></ArticleIdList></Reference><Reference><Citation>Etherington GJ, Ramirez-Gonzalez RH, MacLean D (2015) bio-samtools 2: a package for analysis and visualization of sequence and alignment data with SAMtools in ruby. Bioinformatics 31:2565&#x2013;2567. https://doi.org/10.1093/bioinformatics/btv178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv178</ArticleId><ArticleId IdType="pubmed">25819670</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. https://doi.org/10.1186/gb-2009-10-3-r25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2009-10-3-r25</ArticleId><ArticleId IdType="pubmed">19261174</ArticleId><ArticleId IdType="pmc">2690996</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11:361&#x2013;362. https://doi.org/10.1038/nmeth.2890</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2890</ArticleId><ArticleId IdType="pubmed">24681721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073&#x2013;1081. https://doi.org/10.1038/nprot.2009.86</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2009.86</ArticleId><ArticleId IdType="pubmed">19561590</ArticleId></ArticleIdList></Reference><Reference><Citation>Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248&#x2013;249. https://doi.org/10.1038/nmeth0410-248</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth0410-248</ArticleId><ArticleId IdType="pubmed">20354512</ArticleId><ArticleId IdType="pmc">2855889</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405&#x2013;424. https://doi.org/10.1038/gim.2015.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId><ArticleId IdType="pmc">4544753</ArticleId></ArticleIdList></Reference><Reference><Citation>Piaceri I, Del Mastio M, Tedde A, Bagnoli S, Latorraca S, Massaro F, Paganini M, Corrado A, Sorbi S, Nacmias B (2012) Clinical heterogeneity in Italian patients with amyotrophic lateral sclerosis. Clin Genet 82:83&#x2013;87. https://doi.org/10.1111/j.1399-0004.2011.01726.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2011.01726.x</ArticleId><ArticleId IdType="pubmed">21651514</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Durnall JC, Thoeng AD, Warraich ST, Nicholson GA, Blair IP (2009) A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred. J Neurol Neurosurg Psychiatry 80:1286&#x2013;1288. https://doi.org/10.1136/jnnp.2008.163261</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.163261</ArticleId><ArticleId IdType="pubmed">19864664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N, Pal A, Lojewski X, Corcia P, Naujock M, Reinhardt P, Sterneckert J, Petri S, Wegner F, Storch A, Hermann A (2018) Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol Dis 115:167&#x2013;181. https://doi.org/10.1016/j.nbd.2018.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.03.010</ArticleId><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J, Chen W, Huang P, Xie Y, Zheng M, Yao X (2021) The distinct manifestation of young-onset amyotrophic lateral sclerosis in China. Amyotroph Lateral Scler Frontotemporal Degener 22:30&#x2013;37. https://doi.org/10.1080/21678421.2020.1797091</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1797091</ArticleId><ArticleId IdType="pubmed">32729724</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZJ, Lin HX, Liu GL, Tao QQ, Ni W, Xiao BG, Wu ZY (2017) The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis. Clin Genet 92:267&#x2013;273. https://doi.org/10.1111/cge.13015</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13015</ArticleId><ArticleId IdType="pubmed">28429524</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZJ, Lin HX, Wei Q, Zhang QJ, Chen CX, Tao QQ, Liu GL, Ni W, Gitler AD, Li HF, Wu ZY (2019) Genetic spectrum and variability in Chinese patients with amyotrophic lateral sclerosis. Aging Dis 10:1199&#x2013;1206. https://doi.org/10.4336/AD.2019.0215</Citation><ArticleIdList><ArticleId IdType="doi">10.4336/AD.2019.0215</ArticleId><ArticleId IdType="pubmed">31788332</ArticleId><ArticleId IdType="pmc">6844596</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Wu W, Xie Z, Gang Q, Yu M, Liu J, Wang Q, Lv H, Zhang W, Huang Y, Wang T, Yuan Y, Hong D, Wang Z (2019) Novel and recurrent mutations in a cohort of Chinese patients with young-onset amyotrophic lateral sclerosis. Front Neurosci 13:1289. https://doi.org/10.3389/fnins.2019.01289</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01289</ArticleId><ArticleId IdType="pubmed">31866807</ArticleId><ArticleId IdType="pmc">6908997</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Chen X, Zheng Z, Guo X, Huang R, Cao B, Zeng Y, Shang H (2015) The predictors of survival in Chinese amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 16:237&#x2013;244. https://doi.org/10.3109/21678421.2014.993650</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.993650</ArticleId><ArticleId IdType="pubmed">25581512</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Logroscino G, Boumediene F, Labrunie A, Couratier P, Babron MC, Leutenegger AL, Preux PM, Beghi E (2016) Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol 31:229&#x2013;245. https://doi.org/10.1007/s10654-015-0090-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-015-0090-x</ArticleId><ArticleId IdType="pubmed">26458931</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong HL, Wang JY, Sun YM, Wu JJ, Chen Y, Qiao K, Zheng QJ, Zhao GX, Wu ZY (2010) Association between novel TARDBP mutations and Chinese patients with amyotrophic lateral sclerosis. BMC Med Genet 11:8. https://doi.org/10.1186/1471-2350-11-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-11-8</ArticleId><ArticleId IdType="pubmed">20082726</ArticleId><ArticleId IdType="pmc">2821387</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju X, Liu W, Li X, Liu N, Zhang N, Liu T, Deng M (2016) Two distinct clinical features and cognitive impairment in amyotrophic lateral sclerosis patients with TARDBP gene mutations in the Chinese population. Neurobiol Aging 38:216-e1-216. https://doi.org/10.1016/j.neurobiolaging.2015.10.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.10.032</ArticleId><ArticleId IdType="pubmed">26639158</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu GR, Hu W, Zhan LL, Wang C, Xu LQ, Lin MT, Chen WJ, Wang N, Zhang QJ (2018) High frequency of the TARDBP pM337 V mutation among south-eastern Chinese patients with familial amyotrophic lateral sclerosis. BMC Neurol 18(1):1&#x2013;6. https://doi.org/10.1186/s12883-018-1028-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1028-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Rademakers R, Petrucelli L (2013) TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43. J Alzheimers Dis 33(Suppl 1):S35-45. https://doi.org/10.3233/JAD-2012-129036</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-129036</ArticleId><ArticleId IdType="pubmed">22751173</ArticleId><ArticleId IdType="pmc">3532959</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Valdmanis P, Millecamps S, Lionnet C, Blasco H, Mouzat K, Daoud H, Belzil V, Morales R, Pageot N, Danel-Brunaud V, Vandenberghe N, Pradat PF, Couratier P, Salachas F, Lumbroso S, Rouleau GA, Meininger V, Camu W (2012) Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations. Neurology 78:1519&#x2013;1526. https://doi.org/10.1212/WNL.0b013e3182553c88</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182553c88</ArticleId><ArticleId IdType="pubmed">22539580</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, Sreedharan J, Vance C, Sorenson E, Lippa C, Bigio EH, Geschwind DH, Knopman DS, Mitsumoto H, Petersen RC, Cashman NR, Hutton M, Shaw CE, Boylan KB, Boeve B, Graff-Radford NR, Wszolek ZK, Caselli RJ, Dickson DW, Mackenzie IR, Petrucelli L, Rademakers R (2008) Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 4:e1000193. https://doi.org/10.1371/journal.pgen.1000193</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId><ArticleId IdType="pmc">2527686</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Fu S, Lei J, Wu H, Shi S, Chen K, Hu J, Xu X (2020) Identification of novel FUS and TARDBP gene mutations in Chinese amyotrophic lateral sclerosis patients with HRM analysis. Aging 12:22859&#x2013;22868. https://doi.org/10.8632/aging.103967</Citation><ArticleIdList><ArticleId IdType="doi">10.8632/aging.103967</ArticleId><ArticleId IdType="pubmed">33159016</ArticleId><ArticleId IdType="pmc">7746354</ArticleId></ArticleIdList></Reference><Reference><Citation>Guennoc AM, Heuze-Vourc&#x2019;h N, Gordon PH, Courty Y, Vourc&#x2019;h P, Andres CR, Corcia P (2013) Benign lower limb amyotrophy due to TARDBP mutation or post-polio syndrome? Amyotroph Lateral Scler Frontotemporal Degener 14:476&#x2013;478. https://doi.org/10.3109/21678421.2013.764567</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.764567</ArticleId><ArticleId IdType="pubmed">23356346</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunca C, Seker T, Akcimen F, Coskun C, Bayraktar E, Palvadeau R, Zor S, Kocoglu C, Kartal E, Sen NE, Hamzeiy H, Ozoguz Erimis A, Norman U, Karakahya O, Olgun G, Akgun T, Durmus H, Sahin E, Cakar A, Basar Gursoy E, Babacan Yildiz G, Isak B, Uluc K, Hanagasi H, Bilgic B, Turgut N, Aysal F, Ertas M, Boz C, Kotan D, Idrisoglu H, Soysal A, Uzun Adatepe N, Akalin MA, Koc F, Tan E, Oflazer P, Deymeer F, Tastan O, Cicek AE, Kavak E, Parman Y, Basak AN (2020) Revisiting the complex architecture of ALS in Turkey: expanding genotypes, shared phenotypes, molecular networks, and a public variant database. Hum Mutat 41:e7&#x2013;e45. https://doi.org/10.1002/humu.24055</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.24055</ArticleId><ArticleId IdType="pubmed">32579787</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen F, Anderton RS, Mastaglia FL, Flynn LL, Winter SJ, James I, Bedlack R, Hodgetts S, Fletcher S, Wilton SD, Laing NG, MacShane M, Needham M, Saunders A, Mackay-Sim A, Melamed Z, Ravits J, Cleveland DW, Akkari PA (2021) Novel STMN2 variant linked to amyotrophic lateral sclerosis risk and clinical phenotype. Front Aging Neurosci 13:658226. https://doi.org/10.3389/fnagi.2021.658226</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.658226</ArticleId><ArticleId IdType="pubmed">33841129</ArticleId><ArticleId IdType="pmc">8033025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji AL, Zhang X, Chen WW, Huang WJ (2017) Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum. J Med Genet 54:145&#x2013;154. https://doi.org/10.1136/jmedgenet-2016-104271</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2016-104271</ArticleId><ArticleId IdType="pubmed">28087719</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130&#x2013;133. https://doi.org/10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux MWC (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener 15:45. https://doi.org/10.1186/s13024-020-00397-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId><ArticleId IdType="pmc">7429473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Gautier O, Tassoni-Tsuchida E, Ma XR, Gitler AD (2020) ALS genetics: gains, losses, and implications for future therapies. Neuron 108:822&#x2013;842. https://doi.org/10.1016/j.neuron.2020.08.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId><ArticleId IdType="pmc">7736125</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun CS, Wang CY, Chen BP, He RY, Liu GC, Wang CH, Chen W, Chern Y, Huang JJ (2014) The influence of pathological mutations and proline substitutions in TDP-43 glycine-rich peptides on its amyloid properties and cellular toxicity. PLoS ONE 9:e103644. https://doi.org/10.1371/journal.pone.0103644</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0103644</ArticleId><ArticleId IdType="pubmed">25090004</ArticleId><ArticleId IdType="pmc">4121164</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>